| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |